Rafael Duran

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


87 publications

2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 |
 
Cancer Immunotherapy: A Simple Guide for Interventional Radiologists of New Therapeutic Approaches.
Digklia A., Duran R., Homicsko K., Kandalaft L.E., Hocquelet A., Orcurto A., Coukos G., Denys A., 2019/09. Cardiovascular and interventional radiology, 42 (9) pp. 1221-1229. Peer-reviewed.
 
Immunotherapy and the Interventional Oncologist: Challenges and Opportunities-A Society of Interventional Oncology White Paper.
Erinjeri J.P., Fine G.C., Adema G.J., Ahmed M., Chapiro J., den Brok M., Duran R., Hunt S.J., Johnson D.T., Ricke J. et al., 2019/07. Radiology, 292 (1) pp. 25-34. Peer-reviewed.
 
Erratum to "Percutaneous portal vein recanalization using self-expandable nitinol stents in patients with non-cirrhotic non-tumoral portal vein occlusion" [Diagn. Interv. Imaging 100 (2019) 147-156].
Marot A., Vieira Barbosa J., Duran R., Deltenre P., Denys A., 2019/06..
 
Percutaneous portal vein recanalization using self-expandable nitinol stents in patients with non-cirrhotic non-tumoral portal vein occlusion.
Marot A., Barbosa J.V., Duran R., Deltenre P., Denys A., 2019/03. Diagnostic and interventional imaging, 100 (3) pp. 147-156. Peer-reviewed.
 
Theranostic application of lipiodol for transarterial chemoembolization in a VX2 rabbit liver tumor model.
van Breugel JMM, Geschwind J.F., Mirpour S., Savic L.J., Zhang X., Duran R., Lin M., Miszczuk M., Liapi E., Chapiro J., 2019. Theranostics, 9 (13) pp. 3674-3686. Peer-reviewed.
 
Theranostics in Interventional Oncology: Versatile Carriers for Diagnosis and Targeted Image-Guided Minimally Invasive Procedures.
Degrauwe N., Hocquelet A., Digklia A., Schaefer N., Denys A., Duran R., 2019. Frontiers in pharmacology, 10 p. 450. Peer-reviewed.
 
Hepatocellular carcinoma abutting large vessels: comparison of four percutaneous ablation systems.
Loriaud A., Denys A., Seror O., Vietti Violi N., Digklia A., Duran R., Trillaud H., Hocquelet A., 2018/12. International journal of hyperthermia, 34 (8) pp. 1171-1178. Peer-reviewed.
 
Preoperative Portal Vein Embolization Alone with Biliary Drainage Compared to a Combination of Simultaneous Portal Vein, Right Hepatic Vein Embolization and Biliary Drainage in Klatskin Tumor.
Hocquelet A., Sotiriadis C., Duran R., Guiu B., Yamaguchi T., Halkic N., Melloul E., Demartines N., Denys A., 2018/12. Cardiovascular and interventional radiology, 41 (12) pp. 1885-1891. Peer-reviewed.
 
Local recurrence rate in patients with colorectal cancer liver metastasis after wedge resection or percutaneous radiofrequency ablation.
Vietti Violi N., Duran R., Demartines N., Sempoux C., Guiu B., Bize P.E., Sala N., Halkic N., Knebel J.F., Denys A., 2018/11. International journal of hyperthermia, 34 (7) pp. 1020-1028. Peer-reviewed.
 
Radiofrequency Ablation of Liver Tumors: No Difference in the Ablation Zone Volume Between Cirrhotic and Healthy Liver.
Cassinotto C., Denys A., Gay F., Duran R., Hocquelet A., Piron L., Guiu B., 2018/06. Cardiovascular and interventional radiology, 41 (6) pp. 905-911. Peer-reviewed.
 
Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial.
Vietti Violi N., Duran R., Guiu B., Cercueil J.P., Aubé C., Digklia A., Pache I., Deltenre P., Knebel J.F., Denys A., 2018/05. The lancet. Gastroenterology & hepatology, 3 (5) pp. 317-325. Peer-reviewed.
 
Characteristics of a New X-Ray Imaging System for Interventional Procedures: Improved Image Quality and Reduced Radiation Dose.
Schernthaner R.E., Haroun R.R., Nguyen S., Duran R., Sohn J.H., Sahu S., Chapiro J., Zhao Y., Radaelli A., van der Bom I.M. et al., 2018/03. Cardiovascular and interventional radiology, 41 (3) pp. 502-508. Peer-reviewed.
 
Dexrazoxane prevents skin necrosis in non-target embolization of falciform artery during transcatheter arterial chemoembolization (TACE).
Stalder G., Deplanque G., Shabafrouz K., Orcurto A., Bize P., Duran R., Denys A., 2018/03. Diagnostic and interventional imaging, 99 (3) pp. 179-180. Peer-reviewed.
 
Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?
Zhao Y., Duran R., Bai W., Sahu S., Wang W., Kabus S., Lin M., Han G., Geschwind J.F., 2018/03. Cardiovascular and interventional radiology, 41 (3) pp. 433-442. Peer-reviewed.
 
Heterotopic Gastric Mucosa in a Duplication Cyst of the Common Hepatic Duct Mimicking Cholangiocarcinoma.
Sciarra A., Hessler R., Godat S., Fraga M., Dromain C., Duran R., Halkic N., Sempoux C., 2018/02. International journal of surgical pathology, 26 (1) pp. 84-88. Peer-reviewed.
 
Mapping of drug distribution in the rabbit liver tumor model by complementary fluorescence and mass spectrometry imaging.
Fuchs K., Kiss A., Bize P.E., Duran R., Denys A., Hopfgartner G., Borchard G., Jordan O., 2018/01/10. Journal of controlled release, 269 pp. 128-135. Peer-reviewed.
 
Outcome of elderly patients after acute biliary pancreatitis.
Roulin D., Girardet R., Duran R., Hajdu S., Denys A., Halkic N., Demartines N., Melloul E., 2018. Bioscience trends, 12 (1) pp. 54-59. Peer-reviewed.
 
Drug-eluting embolic microspheres for local drug delivery - State of the art.
Fuchs K., Duran R., Denys A., Bize P.E., Borchard G., Jordan O., 2017/09/28. Journal of controlled release, 262 pp. 127-138. Peer-reviewed.
 
Resin Versus Glass Microspheres for (90)Y Transarterial Radioembolization: Comparing Survival in Unresectable Hepatocellular Carcinoma Using Pretreatment Partition Model Dosimetry.
Van Der Gucht A., Jreige M., Denys A., Blanc-Durand P., Boubaker A., Pomoni A., Mitsakis P., Silva-Monteiro M., Gnesin S., Lalonde M.N. et al., 2017/08. Journal of nuclear medicine, 58 (8) pp. 1334-1340. Peer-reviewed.
 
(18)F-FDG PET/CT predicts survival after (90)Y transarterial radioembolization in unresectable hepatocellular carcinoma.
Jreige M., Mitsakis P., Van Der Gucht A., Pomoni A., Silva-Monteiro M., Gnesin S., Boubaker A., Nicod-Lalonde M., Duran R., Prior J.O. et al., 2017/07. European journal of nuclear medicine and molecular imaging, 44 (7) pp. 1215-1222. Peer-reviewed.
Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?
Sahu S., Schernthaner R., Ardon R., Chapiro J., Zhao Y., Sohn J.H., Fleckenstein F., Lin M., Geschwind J.F., Duran R., 2017/06. Radiology, 283 (3) pp. 883-894. Peer-reviewed.
 
Carcinome hépatocellulaire avancé : nouveautés de la thérapie systémique et place du traitement local ? [Treatment of advanced hepatocellular carcinoma : Novel agents and role of local therapy]
Parisod L., Duran R., Denys A., Digklia A., 2017/05/17. Revue medicale suisse, 13 (563) pp. 1032-1034. Peer-reviewed.
 
RE: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
Duran R., Deltenre P., Denys A., 2017/05. Gastroenterology, 152 (6) pp. 1625-1626. Peer-reviewed.
 
Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra-arterial Therapy.
Sohn J.H., Duran R., Zhao Y., Fleckenstein F., Chapiro J., Sahu S., Schernthaner R.E., Qian T., Lee H., Zhao L. et al., 2017/05. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 15 (5) pp. 746-755.e4. Peer-reviewed.
 
Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion.
Monier A., Guiu B., Duran R., Aho S., Bize P., Deltenre P., Dunet V., Denys A., 2017/04. European radiology, 27 (4) pp. 1431-1439. Peer-reviewed.
 
Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization.
Gorodetski B., Chapiro J., Schernthaner R., Duran R., Lin M., Lee H., Lenis D., Stuart E.A., Nonyane B.A., Pekurovsky V. et al., 2017/02. European radiology, 27 (2) pp. 526-535. Peer-reviewed.
 
Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer.
Duran R., Mirpour S., Pekurovsky V., Ganapathy-Kanniappan S., Brayton C.F., Cornish T.C., Gorodetski B., Reyes J., Chapiro J., Schernthaner R.E. et al., 2017/01/15. Clinical cancer research : an official journal of the American Association for Cancer Research, 23 (2) pp. 536-548. Peer-reviewed.
Clinical significance of pneumatosis intestinalis - correlation of MDCT-findings with treatment and outcome.
Treyaud M.O., Duran R., Zins M., Knebel J.F., Meuli R.A., Schmidt S., 2017/01. European radiology, 27 (1) pp. 70-79. Peer-reviewed.
 
Transarterial Chemoembolization for the Treatment of Advanced-Stage Hepatocellular Carcinoma.
Zhao Y., Duran R., Chapiro J., Sohn J.H., Sahu S., Fleckenstein F., Smolka S., Pawlik T.M., Schernthaner R., Zhao L. et al., 2016/12. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 20 (12) pp. 2002-2009.
Improved Visibility of Metastatic Disease in the Liver During Intra-Arterial Therapy Using Delayed Arterial Phase Cone-Beam CT.
Schernthaner R.E., Haroun R.R., Duran R., Lee H., Sahu S., Sohn J.H., Chapiro J., Zhao Y., Gorodetski B., Fleckenstein F. et al., 2016/10. Cardiovascular and interventional radiology, 39 (10) pp. 1429-1437. Peer-reviewed.
Renal Cell Carcinoma Metastatic to the Liver: Early Response Assessment after Intraarterial Therapy Using 3D Quantitative Tumor Enhancement Analysis.
Fleckenstein F.N., Schernthaner R.E., Duran R., Sohn J.H., Sahu S., Marshall K., Lin M., Gebauer B., Chapiro J., Salem R. et al., 2016/10. Translational oncology, 9 (5) pp. 377-383. Peer-reviewed.
 
3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival.
Fleckenstein F.N., Schernthaner R.E., Duran R., Sohn J.H., Sahu S., Zhao Y., Hamm B., Gebauer B., Lin M., Geschwind J.F. et al., 2016/09. European radiology, 26 (9) pp. 3243-3252. Peer-reviewed.
 
Early sorafenib-related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients.
Zhao Y., Li H., Bai W., Liu J., Lv W., Sahu S., Guan S., Qin X., Wang W., Ren W. et al., 2016/08/15. International journal of cancer, 139 (4) pp. 928-937. Peer-reviewed.
 
Early sorafenib-related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients.
Zhao Y., Li H., Bai W., Liu J., Lv W., Sahu S., Guan S., Qin X., Wang W., Ren W. et al., 2016/08/15. International journal of cancer, 139 (4) pp. 928-937. Peer-reviewed.
 
Antitumoral Effect of Sunitinib-eluting Beads in the Rabbit VX2 Tumor Model.
Bize P., Duran R., Fuchs K., Dormond O., Namur J., Decosterd L.A., Jordan O., Doelker E., Denys A., 2016/08. Radiology, 280 (2) pp. 425-435. Peer-reviewed.
 
Chemoembolization with Drug-Eluting Beads
Duran Rafael, Geschwind Jean-François, 2016/03/01. pp. 330-337 dans Embolization Therapy: Principles and Clinical Applications 9781496305992 chap. 36, Lippincott Williams & Wilkins.
 
Transcatheter Arterial Chemoembolization (Conventional and with Drug-Eluting Beads) and Radioembolization)
Duran Rafael, Geschwind Jean-François, 2016/03/01. pp. 354-358 dans Embolization Therapy: Principles and Clinical Applications - 9781496305992 chap. 39, Lippincott Williams & Wilkins .
 
A Novel Inherently Radiopaque Bead for Transarterial Embolization to Treat Liver Cancer - A Pre-clinical Study.
Duran R., Sharma K., Dreher M.R., Ashrafi K., Mirpour S., Lin M., Schernthaner R.E., Schlachter T.R., Tacher V., Lewis A.L. et al., 2016. Theranostics, 6 (1) pp. 28-39. Peer-reviewed.
Automatic bone removal for 3D TACE planning with C-arm CBCT: Evaluation of technical feasibility.
Wang Z., Hansis E., Chen R., Duran R., Chapiro J., Sheu Y.R., Kobeiter H., Grass M., Geschwind J.F., Lin M., 2016. Minimally Invasive Therapy and Allied Technologies, 25 (3) pp. 162-170. Peer-reviewed.
Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.
Tacher V., Lin M., Duran R., Yarmohammadi H., Lee H., Chapiro J., Chao M., Wang Z., Frangakis C., Sohn J.H. et al., 2016. Radiology, 278 (1) pp. 275-284. Peer-reviewed.
 
Multimodality Imaging of Ethiodized Oil-loaded Radiopaque Microspheres during Transarterial Embolization of Rabbits with VX2 Liver Tumors.
Tacher V., Duran R., Lin M., Sohn J.H., Sharma K.V., Wang Z., Chapiro J., Gacchina Johnson C., Bhagat N., Dreher M.R. et al., 2016. Radiology, 279 (3) pp. 741-753. Peer-reviewed.
Radiologic-pathologic analysis of quantitative 3D tumour enhancement on contrast-enhanced MR imaging: a study of ROI placement.
Chockalingam A., Duran R., Sohn J.H., Schernthaner R., Chapiro J., Lee H., Sahu S., Nguyen S., Geschwind J.F., Lin M., 2016/01. European Radiology, 26 (1) pp. 103-113. Peer-reviewed.
A new angiographic imaging platform reduces radiation exposure for patients with liver cancer treated with transarterial chemoembolization.
Schernthaner R.E., Duran R., Chapiro J., Wang Z., Geschwind J.F., Lin M., 2015/11. European Radiology, 25 (11) pp. 3255-3262. Peer-reviewed.
 
Three-Dimensional Quantitative Assessment of Lesion Response to MR-guided High-Intensity Focused Ultrasound Treatment of Uterine Fibroids.
Savic L.J., Lin M.D., Duran R., Schernthaner R.E., Hamm B., Geschwind J.F., Hong K., Chapiro J., 2015/09. Academic Radiology, 22 (9) pp. 1199-1205. Peer-reviewed.
 
How to Prepare a Patient for Transarterial Radioembolization? A Practical Guide.
Denys A., Pracht M., Duran R., Guiu B., Adib S., Boubaker A., Bize P., 2015/08. Cardiovascular and Interventional Radiology, 38 (4) pp. 794-805. Peer-reviewed.
Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions.
Duran R., Chapiro J., Schernthaner R.E., Geschwind J.F., 2015/08. British Journal of Radiology, 88 (1052) p. 20140564. Peer-reviewed.
Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
Wang Z., Chapiro J., Schernthaner R., Duran R., Chen R., Geschwind J.F., Lin M., 2015/07. Academic Radiology, 22 (7) pp. 840-845. Peer-reviewed.
Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRI.
Chapiro J., Lin M., Duran R., Schernthaner R.E., Geschwind J.F., 2015. Expert Review of Anticancer Therapy, 15 (2) pp. 199-205. Peer-reviewed.
 
Characterization of fortuitously discovered focal liver lesions: additional information provided by shearwave elastography.
Ronot M., Di Renzo S., Gregoli B., Duran R., Castera L., Van Beers B.E., Vilgrain V., 2015. European Radiology, 25 (2) pp. 346-358. Peer-reviewed.
 
Chemoembolization (Conventional and with Drug-Eluting Beads) and Radioembolization/Section H: Hepatic Embolization
Chapiro J., Duran R., Geschwind JF., 2015/01. pp. 354-358 dans Guimaraes Marcelo Pinto, Lencioni Riccardo, Siskin Gary P. (eds.) Embolization Therapy: Principles and Clinical Applications, Lippincott Williams and Wilkins.
 
Chemoembolization with Drug-Eluting Beads/Section H: Hepatic Embolization
Chapiro J., Duran R., Geschwind JF., 2015/01. pp. 330-336 dans Guimaraes Marcelo Pinto, Lencioni Riccardo, Siskin Gary P. (eds.) Embolization Therapy: Principles and Clinical Applications, Lippincott Williams and Wilkins.
 
Delayed-Phase Cone-Beam CT Improves Detectability of Intrahepatic Cholangiocarcinoma During Conventional Transarterial Chemoembolization.
Schernthaner R.E., Lin M., Duran R., Chapiro J., Wang Z., Geschwind J.F., 2015. Cardiovascular and Interventional Radiology, 38 (4) pp. 929-936. Peer-reviewed.
Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.
Chapiro J., Duran R., Lin M., Schernthaner R., Lesage D., Wang Z., Savic L.J., Geschwind J.F., 2015. European Radiology, 25 (7) pp. 1993-2003. Peer-reviewed.
Feasibility of a Modified Cone-Beam CT Rotation Trajectory to Improve Liver Periphery Visualization during Transarterial Chemoembolization.
Schernthaner R.E., Chapiro J., Sahu S., Withagen P., Duran R., Sohn J.H., Radaelli A., van der Bom I.M., Geschwind J.F., Lin M., 2015. Radiology, 277 (3) pp. 833-841. Peer-reviewed.
 
How I do it: a practical database management system to assist clinical research teams with data collection, organization, and reporting.
Lee H., Chapiro J., Schernthaner R., Duran R., Wang Z., Gorodetski B., Geschwind J.F., Lin M., 2015. Academic Radiology, 22 (4) pp. 527-533. Peer-reviewed.
 
Identifying Staging Markers for Hepatocellular Carcinoma before Transarterial Chemoembolization: Comparison of Three-dimensional Quantitative versus Non-three-dimensional Imaging Markers.
Chapiro J., Duran R., Lin M., Schernthaner R.E., Wang Z., Gorodetski B., Geschwind J.F., 2015. Radiology, 275 (2) pp. 438-447. Peer-reviewed.
 
Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
Wang Z., Chen R., Duran R., Zhao Y., Yenokyan G., Chapiro J., Schernthaner R., Radaelli A., Lin M., Geschwind J.F., 2015. Cardiovascular and Interventional Radiology, 38 (6) pp. 1548-1556. Peer-reviewed.
 
Is magnetic resonance imaging of hepatic hemangioma any different in liver fibrosis and cirrhosis compared to normal liver?
Duran R., Ronot M., Di Renzo S., Gregoli B., Van Beers B.E., Vilgrain V., 2015. European Journal of Radiology, 84 (5) pp. 816-822. Peer-reviewed.
Three-Dimensional Quantitative Assessment of Uterine Fibroid Response after Uterine Artery Embolization Using Contrast-Enhanced MR Imaging.
Chapiro J., Duran R., Lin M., Werner J.D., Wang Z., Schernthaner R., Savic L.J., Lessne M.L., Geschwind J.F., Hong K., 2015. Journal of Vascular and Interventional Radiology : Jvir, 26 (5) pp. 670-678.e2. Peer-reviewed.
Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver - the use of imaging biomarkers as predictors of patient survival.
Chapiro J., Duran R., Lin M., Mungo B., Schlachter T., Schernthaner R., Gorodetski B., Wang Z., Geschwind J.F., 2015. European Journal of Radiology, 84 (3) pp. 424-430. Peer-reviewed.
 
Acute mesenteric vein thrombosis: factors associated with evolution to chronic mesenteric vein thrombosis
Vietti Violi N., Fournier N., Duran R., Schmidt S., Bize P., Guiu B., Denys A., 2014. AJR. American Journal of Roentgenology, 203 (1) pp. 54-61. Peer-reviewed.
 
Combination of intra-arterial therapies and sorafenib: is there a clinical benefit?
Chapiro J., Duran R., Geschwind J.F., 2014. La Radiologia Medica, 119 (7) pp. 476-482. Peer-reviewed.
 
Hepatic hemangiomas: Factors associated with T2 shine-through effect on diffusion-weighted MR sequences.
Duran R., Ronot M., Kerbaol A., Van Beers B., Vilgrain V., 2014. European Journal of Radiology, 83 (3) pp. 468-478. Peer-reviewed.
 
Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis.
Chapiro J., Wood L.D., Lin M., Duran R., Cornish T., Lesage D., Charu V., Schernthaner R., Wang Z., Tacher V. et al., 2014. Radiology, 273 (3) pp. 746-758. Peer-reviewed.
Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer.
Chapiro J., Sur S., Savic L.J., Ganapathy-Kanniappan S., Reyes J., Duran R., Thiruganasambandam S.C., Moats C.R., Lin M., Luo W. et al., 2014. Clinical Cancer Research, 20 (24) pp. 6406-6417. Peer-reviewed.
Three-dimensional evaluation of lipiodol retention in HCC after chemoembolization: a quantitative comparison between CBCT and MDCT.
Wang Z., Lin M., Lesage D., Chen R., Chapiro J., Gu T., Tacher V., Duran R., Geschwind J.F., 2014. Academic Radiology, 21 (3) pp. 393-399. Peer-reviewed.
 
Use of high-frequency jet ventilation for percutaneous tumor ablation.
Denys A., Lachenal Y., Duran R., Chollet-Rivier M., Bize P., 2014. Cardiovascular and Interventional Radiology, 37 (1) pp. 140-146. Peer-reviewed.
Uveal Melanoma Metastatic to the Liver: The Role of Quantitative Volumetric Contrast-Enhanced MR Imaging in the Assessment of Early Tumor Response after Transarterial Chemoembolization.
Duran R., Chapiro J., Frangakis C., Lin M., Schlachter T.R., Schernthaner R.E., Wang Z., Savic L.J., Tacher V., Kamel I.R. et al., 2014. Translational Oncology, 7 (4) pp. 447-455. Peer-reviewed.
 
MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours.
Ronot M., Paradis V., Duran R., Kerbaol A., Vullierme M.P., Belghiti J., Valla D.C., Vilgrain V., 2013/04. European Radiology, 23 (4) pp. 914-923. Peer-reviewed.
 
Intrahepatic Cholangiocarcinoma: Diffusion-Weighted MR Imaging Findings
Schmidt Sabine, Pomoni Anastasia, Becce Fabio, Denys Alban, Meuli Reto, Duran Rafael (eds.), 2013/03/07., European Society of Radiology, 25th Annual Meeting.
 
Improved bleeding control and hemodynamic stability after embolization in unstable polytrauma patients.
Aguet J., Bize P., Duran R., Demartines N., Denys A., 2013. dans USSMV-USGG 2013, 14e Congrès de l'Union des Sociétés Suisses des Maladies Vasculaires.
 
In vitro and in vivo evaluation of sunitinib eluting beads
Bize P., Jordan O., Fuchs K., Dormond O., Duran R., Doelker E., De Baere T., Denys A., 2013. pp. Abstract 246 dans 2013 Gastrointestinal Cancers Symposium, Journal of Clinical Oncology.
 
Thérapie par Cryoablation Percutanée Ciblée: Comment Dois-je Faire?
Pomoni Anastasia, Duran Rafael, Meuli Reto, Denys Alban, Bize Pierre (eds.), 2012/10/19., Journées Françaises de Radiologie, 60th Annual Meeting.
 
Embolization for multicompartmental bleeding in patients in hemodynamically unstable condition: prognostic factors and outcome.
Bize P.E., Duran R., Madoff D.C., Golliet-Mercier N., Heim C., Pilleul F., Demartines N., Denys A., 2012. Journal of Vascular and Interventional Radiology, 23 (6) pp. 751-760.e4.
 
Evaluation of high frequency jet ventilation in patients undergoing percutaneous thermal ablation
Bize P., Duran R., Chollet M., Denys A., 2012. dans SIR 2012, 37th Annual Meeting of the Society of Interventional Radiology.
 
In vivo characterization of sunitinib eluting beads
Bize P., Jordan O., Dormond O., Duran R., Doelker E., De Baere T., Denys A., 2012. dans SIR 2012, 37th Annual Meeting of the Society of Interventional Radiology.
 
In vivo evaluation of sunitinib-loaded DC Bead
Bize P., Jordan O., Dormond O., Duran R., Doelker E., de Baere T., Denys A., 2012. dans CIRSE 2012, Annual Congress and Postgraduate Course of the Cardiovascular and Interventional Radiological Society of Europe.
 
In vivo evaluation of the anti-tumoral effect of sunitinib eluting beads in the rabbit VX2 tumor model
Bize P., Jordan O., Dormond O., Duran R., Doelker E., De Baere T., Denys A., 2012. dans SIR 2012, 37th Annual Meeting of the Society of Interventional Radiology.
 
In vivo evaluation of the anti-tumoral effect of sunitinib-eluting beads in the rabbit VX2 tumor model
Bize P., Jordan O., Dormond O., Duran R., Doelker E., de Baere T., Denys A., 2012. dans CIRSE 2012, Annual Congress and Postgraduate Course of the Cardiovascular and Interventional Radiological Society of Europe.
 
In-Vivo Pharmacokinetics of DC-Beads Loaded with Sunitinib in an Animal Model
Bize P., Jordan O., Dormond O., Duran R., Doelker E., De Baere T., Denys A., 2012. dans GEST 2012, Global Embolization Symposium and Technolgies.
 
La contribution de la radiologie interventionnelle.
Denys A., Duran R., Bize P., 2012. dans JFR 2012, 60e Journées Françaises de Radiologie, 33e Journées Francophones de Radiologie.
 
Multidetector CT Features of Mesenteric Vein Thrombosis.
Duran R., Denys A.L., Letovanec I., Meuli R.A., Schmidt S., 2012. Radiographics, 32 (5) pp. 1503-1522. Peer-reviewed.
 
Portal vein embolization: what do we know?
Denys A., Prior J., Bize P., Duran R., De Baere T., Halkic N., Demartines N., 2012. Cardiovascular and Interventional Radiology, 35 (5) pp. 999-1008. Peer-reviewed.
 
Targeted percutaneous cryoablation therapy: How should I do?
Pomoni A., Duran R., Denys A., Bize P., 2012. dans SSR 2012, 99th Annual Meeting of the Swiss Society of Radiology.
 
CHE en dehors du CHC : rationnel, indications, résultats.
Denys A., Duran R., Bize P., 2011. dans JFR 2011, 59e Journées Françaises de Radiologie, 32e Journées Francophones de Radiologie.
 
Mesenteric Venous Thrombosis: MDCT Features according to the Underlying Etiology and Associated Venous Bowel Ischemia
Duran Rafael, Denys Alban, Meuli Reto, Schmidt Sabine (eds.), 2010/12/03., Radiological Society of North America 2010 Scientific Assembly and Annual Meeting.
 
Radiological profile of anemia on unenhanced MDCT of the thorax.
Kamel E.M., Rizzo E., Duchosal M.A., Duran R., Goncalves-Matoso V., Schnyder P., Qanadli S.D., 2008. European Radiology, 18 (9) pp. 1863-1868. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University